Evaluation of Endometrial Abnormalities in Asymptomatic Postmenopausal Women with Endometrial Thickening
- PMID: 40390876
- PMCID: PMC12085496
- DOI: 10.1007/s13224-024-01979-5
Evaluation of Endometrial Abnormalities in Asymptomatic Postmenopausal Women with Endometrial Thickening
Abstract
Background: Endometrial cancer is a prevalent gynecological malignancy typically characterized by abnormal uterine bleeding in postmenopausal women, although it can also manifest in asymptomatic patients. Asymptomatic postmenopausal women often display endometrial thickening, and research has shown associations between endometrial thicknesses of 5 mm or more and certain pathologies. However, it remains unclear whether specific pathologies are related to different diameters of thickened endometrium.
Aim: The purpose of this study was to evaluate the relationship between the diameters of endometrial thickness its histopathology, and the related symptoms in postmenopausal women who have incidental endometrial thickening and are not experiencing vaginal bleeding.
Methods: This study was conducted in Alzahra Teaching Hospital of Tabriz University of Medical Sciences. The inclusion criteria for the study comprised of postmenopausal women who had visited the clinics with symptoms other than vaginal bleeding and exhibited an endometrial thickness of more than 5 mm in ultrasound imaging. A total of eighty-four women were included in the final analysis. The participants were scheduled to undergo a Pap smear and endometrial biopsy (Pipelle biopsy). The histopathology of the endometrial samples was examined to test the research hypothesis.
Results: There was no statistically significant association between endometrial histopathologic findings and endometrial diameter (p-value = 0.12) or participants' chief complaints (p-value = 0.21).
Conclusion: Our findings indicate that endometrial thickening is not a reliable predictor for a specific endometrial pathology in postmenopausal women who do not experience vaginal bleeding.
Keywords: Asymptomatic endometrial thickness; Endometrial neoplasms; Endometrial sampling; Polyps; Post-menopause; Ultrasonography.
© Federation of Obstetric & Gynecological Societies of India 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestThe authors have no relevant financial or non-financial conflict of interests.
Similar articles
-
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. doi: 10.1002/14651858.CD002126.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2015 Apr 30;(4):CD002126. doi: 10.1002/14651858.CD002126.pub3. PMID: 16235297 Updated.
-
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.Cochrane Database Syst Rev. 2002;(3):CD001124. doi: 10.1002/14651858.CD001124. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2014 Jul 29;(7):CD001124. doi: 10.1002/14651858.CD001124.pub2. PMID: 12137619 Updated.
-
Local oestrogen for vaginal atrophy in postmenopausal women.Cochrane Database Syst Rev. 2016 Aug 31;2016(8):CD001500. doi: 10.1002/14651858.CD001500.pub3. Cochrane Database Syst Rev. 2016. PMID: 27577677 Free PMC article.
-
Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.Cochrane Database Syst Rev. 2004;(3):CD000402. doi: 10.1002/14651858.CD000402.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000402. doi: 10.1002/14651858.CD000402.pub3. PMID: 15266429 Updated.
-
Short-term and long-term effects of tibolone in postmenopausal women.Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD008536. doi: 10.1002/14651858.CD008536.pub3. Cochrane Database Syst Rev. 2016. PMID: 27733017 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: Cancer J Clin. 2019;69(1):7–34. - PubMed
-
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. - PubMed
-
- Rezaianzadeh A, Dehghani SL, Mousavi M, et al. The incidence of uterus cancer in Iran: a systematic review. Women’s Health Bull. 2017;4(1):1–4. 10.17795/whb-42917.
LinkOut - more resources
Research Materials